A prospective analysis of CT density measurements of bone metastases after treatment with zoledronic acid

被引：0
作者：
Carlo C. Quattrocchi
Daniele Santini
Paola Dell’Aia
Sara Piciucchi
Emanuele Leoncini
Bruno Vincenzi
Rosario Francesco Grasso
Giuseppe Tonini
Bruno Beomonte Zobel
机构：
[1] Centro Interdisciplinare per la Ricerca Bio-Medica,Department of Radiology
[2] University Campus Bio-Medico di Roma,Department of Oncology
[3] Statistica Sanitaria,undefined
[4] University La Sapienza,undefined
来源：
Skeletal Radiology | 2007年 / 36卷
关键词：
Bone metastases; Computed tomography; Zoledronic acid;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1127
页数：6
相关论文
共 50 条
  • [31] Zoledronic acid delays disease progression of bone metastases from hepatocellular carcinoma
    Katamura, Yoshio
    Aikata, Hiroshi
    Hashimoto, Yoshimasa
    Kimura, Yuki
    Kawaoka, Tomokazu
    Takaki, Shintaro
    Waki, Koji
    Hiramatsu, Akira
    Kawakami, Yoshiiku
    Takahashi, Shoichi
    Kenjo, Masahiro
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2010, 40 (12) : 1195 - 1203
  • [32] Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
    Chen, Fengxia
    Pu, Feifei
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 453 - 459
  • [33] Efficacy and Safety of Denosumab Versus Zoledronic Acid in Patients With Bone Metastases A Systematic Review and Meta-analysis
    Sun, Lei
    Yu, Shiying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (04): : 399 - 403
  • [34] Tumoricidal effect and pain relief after concurrent therapy by strontium-89 chloride and zoledronic acid for bone metastases
    Baba, Kenkichi
    Kaida, Hayato
    Hattori, Chikayuki
    Muraki, Koichiro
    Kugiyama, Tomoko
    Fujita, Hiromasa
    Ishibashi, Masatoshi
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2018, 21 (01): : 15 - 23
  • [35] Bone markers for monitoring efficacy in patients with bone metastases receiving zoledronic acid: a review of published data
    Huang, Qian
    Ouyang, Xuenong
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2013, 28 (03) : 242 - 248
  • [36] Efficacy of zoledronic acid in the prevention of bone metastases in patients with locally advanced prostate cancer
    Musaev, T. N.
    Zeinalov, B. S.
    Kerimov, A. Kh.
    Guliev, F. A.
    Musaev, I. N.
    Alizade, A. M.
    Adzhalov, O. V.
    ONKOUROLOGIYA, 2011, 7 (01): : 62 - 65
  • [37] Well-Differentiated Hand Liposarcoma with Bone Metastases Treated Successfully with Zoledronic Acid
    Mystakidou, Kyriaki
    Panagiotou, Irene
    Brountzos, Elias
    Kouloulias, Vassilios
    Gouliamos, Athanasios
    ONKOLOGIE, 2011, 34 (12): : 706 - 709
  • [38] Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors
    T. Van den Wyngaert
    M. Delforge
    C. Doyen
    L. Duck
    K. Wouters
    I. Delabaye
    C. Wouters
    H. Wildiers
    Supportive Care in Cancer, 2013, 21 : 3483 - 3490
  • [39] Prospective observational study of treatment pattern, effectiveness and safety of zoledronic acid therapy beyond 24 months in patients with multiple myeloma or bone metastases from solid tumors
    Van den Wyngaert, T.
    Delforge, M.
    Doyen, C.
    Duck, L.
    Wouters, K.
    Delabaye, I.
    Wouters, C.
    Wildiers, H.
    SUPPORTIVE CARE IN CANCER, 2013, 21 (12) : 3483 - 3490
  • [40] Zoledronic Acid Treatment of Bone Metastasis in Urology
    Aydin, Muammer
    Tandogdu, Zafer
    Ozkan, Arif
    JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2013, 3 (01): : 5 - 7
12345